Authors urge redesign of insulin pumps for pregnant women with T1D

A commentary states that automated insulin delivery (AID) systems, now the recommended mode of insulin delivery for type 1 diabetes, are not designed to meet the lower, pregnancy-specific glycemic targets and are largely not labeled for pregnancy use. The authors note that pregnant women have been broadly excluded from AID clinical trials, leaving limited data to guide device use in pregnancy, and that most current systems reduce insulin delivery when CGM values are in the range considered optimal for fetal well-being. They call for including pregnant women in future AID trials, designing systems suited to pregnancy's glycemic demands, and supporting real-world studies of currently approved devices.

Most relevant for: Pregnant women with type 1 diabetes managing glycemic control with insulin delivery devices.

Summary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.

Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.